Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma

References

• Li H, Huang C, Chen Q, et al. Lymph-node Epstein-Barr virus concentration in diagnosing cervical lymph-node metastasis in nasopharyngeal carcinoma.Eur Arch Otorhinolaryngol. . 2020Sep; 2779: 2513–2520
   PubMed Web of Science ®Google Scholar
• Sun XS, Li XY, Chen QY, et al. Future of Radiotherapy in Nasopharyngeal Carcinoma. Br J Radiol. 2019 Oct;92(1102):20190209.
   PubMed Web of Science ®Google Scholar
• Holmes BJ, Wenig BM. Virus-associated carcinomas of the head & neck: update from the 2017 WHO classification. Ann Diagn Pathol. 2019 Feb;38:29–42.
   PubMed Web of Science ®Google Scholar
• Lee HM, Okuda KS, González FE, et al. Current Perspectives on Nasopharyngeal Carcinoma. Adv Exp Med Biol. 2019;1164:11–34.
   PubMed Web of Science ®Google Scholar
• Guan S, Wei J, Huang L, et al. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma. Eur J Med Chem. 2020 Dec 1;207:112758.
   PubMed Web of Science ®Google Scholar
• Hong M, Tang K, Qian J, et al. Immunotherapy for EBV-Associated Nasopharyngeal Carcinoma. Crit Rev Oncog. 2018;23(3–4):219–234.
   PubMedGoogle Scholar
• Lee AWM, Ng WT, Chan JYW, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019 Sep;79:101890.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen T. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6. Mol Med Rep. 2021 Jan;23(1):23.
   PubMed Web of Science ®Google Scholar
• Ashok C, Owais S, Srijyothi L, et al. A feedback regulation of CREB activation through the CUL4A and ERK signaling. Med Oncol. 2019 Jan 21 36(2):20.
   PubMed Web of Science ®Google Scholar
• Cui H, Wang Q, Lei Z, et al. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation. J Exp Clin Cancer Res. 2019 Aug 13 38(1):350.
   PubMed Web of Science ®Google Scholar
• Mei Q, Ye LJ, Lin H, et al. CUL4A promotes the invasion of cervical cancer cells by regulating NF-κB signaling pathway. Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10403–10409.
   PubMed Web of Science ®Google Scholar
• Ni W, Zhang Y, Zhan Z, et al. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J Hematol Oncol. 2017 Apr 19 10(1):91.
   PubMedGoogle Scholar
• Hung MS, Chen YC, Lin P, et al. Cul4A Modulates Invasion and Metastasis of Lung Cancer Through Regulation of ANXA10. Cancers (Basel). 2019 May 2 11(5):618.
   PubMed Web of Science ®Google Scholar
• Yi LJ, Yi LJ, Ding N, et al. CUL4A promotes proliferation and inhibits apoptosis of colon cancer cells via regulating Hippo pathway. Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10518–10525.
   PubMed Web of Science ®Google Scholar
• Chen HH, Fan P, Chang SW, et al. NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer. Oncotarget. 2017 Mar 28 8(13):21501–21515.
   PubMedGoogle Scholar
• Jin X, Ma YC, Zhu WY, et al. CUL4A expression is associated with tumor stage and prognosis in nasopharyngeal carcinoma. Medicine (Baltimore). 2019 Dec;98(51):e18036.
   PubMed Web of Science ®Google Scholar
• Li M, Huang H, Cheng F, et al. miR-141-3p promotes proliferation and metastasis of nasopharyngeal carcinoma by targeting NME1. Adv Med Sci. 2020 Sep;65(2):252–258.
   PubMed Web of Science ®Google Scholar
• Chan KC, Ting CM, Chan PS, et al. A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation. Mol Cancer. 2013 Oct 24 12(1):128.
   PubMedGoogle Scholar
• Yu X, Lin XJ, Wang S, et al. Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft. Integr Cancer Ther. 2018 Dec;17(4):1216–1224.
   PubMed Web of Science ®Google Scholar
• Gallo-Oller G, Ordoñez R, Dotor J. A new background subtraction method for Western blot densitometry band quantification through image analysis software. J Immunol Methods. 2018 Jun;457:1–5.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego. Calif). 2001 Dec;25(4):402–408.
   Google Scholar
• Pan S, Deng Y, Fu J, et al. TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling. Cancer Cell Int. 2019;19(1):57.
   PubMedGoogle Scholar
• Sun S, Gao T, Pang B, et al. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m(6)A-dependent manner. Cell Death Dis. [2022 Jan 21];13(1):73.
   PubMed Web of Science ®Google Scholar
• He L, Zhu C, Jia J, et al. ADSC-Exos containing MALAT1 promotes wound healing by targeting miR-124 through activating Wnt/β-catenin pathway. Biosci Rep. 2020 May 29;40(5). 10.1042/BSR20192549.
   Google Scholar
• Wu D, Kang L, Tian J, et al. Exosomes Derived from Bone Mesenchymal Stem Cells with the Stimulation of Fe(3)O(4) Nanoparticles and Static Magnetic Field Enhance Wound Healing Through Upregulated miR-21-5p. Int J Nanomedicine. 2020;15:7979–7993.
   PubMed Web of Science ®Google Scholar
• Wang C, Cheng Y, Liu H, et al. Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma. Cell Physiol Biochem. 2016;39(5):1795–1803.
   PubMedGoogle Scholar
• Franz M, Rodriguez H, Lopes C, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018 Jul 2 46(W1):W60–w64.
   PubMed Web of Science ®Google Scholar
• Guo R, Mao YP, Tang LL, et al. The evolution of nasopharyngeal carcinoma staging. Br J Radiol. 2019 Oct;92(1102):20190244.
   PubMed Web of Science ®Google Scholar
• Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet (London. England). [2019 Jul 6];394(10192):64–80.
   Google Scholar
• Song Y, Xiao H, Yang Z, et al. The predictive value of pre- and post-induction chemotherapy plasma EBV DNA level and tumor volume for the radiosensitivity of locally advanced nasopharyngeal carcinoma. EXCLI J. 2017;16:1268–1275.
   PubMed Web of Science ®Google Scholar
• Ji Y, Li H, Wang F, et al. PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis. Front Pharmacol. 2018;9:648.
   PubMed Web of Science ®Google Scholar
• Wakae K, Kondo S, Pham HT, et al. EBV-LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer. Cancer Med. 2020 Oct;9(20):7663–7671.
   PubMed Web of Science ®Google Scholar
• Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc London, Ser B. 2017 Oct 19;372:20160270.
   PubMed Web of Science ®Google Scholar
• Schnappauf O, Aksentijevich I. Mendelian diseases of dysregulated canonical NF-κB signaling: from immunodeficiency to inflammation. J Leukoc Biol. 2020 Aug;108(2):573–589.
   PubMed Web of Science ®Google Scholar
• Liang Y, Feng G, Wu L, et al. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway. Drug Des Devel Ther. 2019;13:1335–1345.
   PubMed Web of Science ®Google Scholar
• Yang D, Liang T, Gu Y, et al. Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma. Oncol Rep. 2016 Mar;35(3):1703–1710.
   PubMed Web of Science ®Google Scholar
• Sloan SL, Renaldo KA, Long M, et al. Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma. PloS one. 2021;16(5):e0250839.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Nie H. Protein arginine methyltransferase 5: a potential cancer therapeutic target. Cell Oncol (Dordr). 2021 Feb;44(1):33–44.
   PubMed Web of Science ®Google Scholar